Quantcast

The US Drug Watchdog Calls its Vital Yaz Yasmin Birth Control Pill Initiative its Most Important Women’s Health Campaign Ever & Because of Heart Attacks & Strokes

February 10, 2012

According to the US Drug Watchdog, “On Saturday February 4th 2012, we received an e-mail from a young woman, who at 19 years old, suffered a stroke, while using the birth control pill cal Yaz. She was an athlete, with no known health issues. Our Yaz, Yasmin, or generic version Ocella birth control pill initiative is now officially our most important women’s health initiative ever. We are also very focused on women who used Yaz, Yasmin, or Ocella, and had a heart attack, or developed other severe medical complications.” As a background, in September of 2009, the US FDA released a warning letter sent to Bayer Pharmaceuticals over Yaz & Yasmin. The letter indicates that the drug maker hid out-of-specification test results for key ingredients in the birth control pills, and said that several batches of the drugs should have never been released to the public. The US Drug Watchdog says, “If you, or a friend are using birth control pills called Yaz, Yasmin, or their generic version Ocella, and severe side effects have occurred, such a pulmonary embolism, a heart attack, a stroke, or other severe medical conditions please contact us immediately at 866-714-6466 or http://USDrugWatchdog.com."

(PRWEB) February 10, 2012

The US Drug Watchdog is the premier private advocacy group in the United States for victims of dangerous pharmaceuticals, or medical devices. The group is expanding its initiative related to the birth control pills called Yaz, Yasmin, and the generic version called Ocella. The group says, “We are dramatically expanding our ongoing national investigation of the birth control pills called Yaz, Yasmin, and Ocella, over concern that the use of these drugs could be associated with pulmonary embolisms, strokes, heart attacks, blood clots, and other very serious health side affects.” According to the September 17th 2009 edition of the New York Times, “The FDA released a warning letter sent in September to Bayer Pharmaceuticals over Yaz & Yasmin. The letter indicates that the drug maker hid out-of-specification test results for key ingredients in the birth control pills, and said that several batches of the drugs should have never been released to the public.The FDA letter was also very critical of the drug maker for failing to highlight the risk factors associated with these birth control pills. They US Drug Watchdog says, “If a user of the birth control pills called Yaz, Yasmin, or the generic version Ocella has had a pulmonary embolism, a heart attack, stroke, blood clotting, or other serious medical issues, they should contact our group immediately at 866-714-6466.” http://USDrugWatchdog.com

Possible Side Effects Yaz/Yasmin

  • Yaz / Yasmin Stroke or Heart attack
  • Yaz / Yasmin Pulmonary Embolism
  • Yaz / Yasmin Deep Vein Thrombosis
  • Sudden Death from Yaz or Yasmin

The US Drug Watchdog is saying,”We want to talk with users of the birth control pills called Yaz, Yasmin, or the generic version Ocella, if they have had any type of severe medical side effects, or, who have suddenly developed an unexplained severe medical condition. We want to get the word out to all women about these drugs, because of the potential for heart attacks, strokes, and or other serious medical issues, and time really is of the essence.” For more information please call the US Drug Watchdog anytime at 866-714-6466, or contact the group via its web site at http://USDrugWatchdog.com

MDL No. 2100 (3:09-md-02100-DRH-PMF)

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/2/prweb9177235.htm


Source: prweb



comments powered by Disqus